Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

The pharmacokinetics and conversion of the lactone to the carboxylate forms of ginkgolide B in rat plasma.

Wang DL, Peng DY, Tao XH, Cao Y, Chen WD, Liang Y, Xie L, Liu XD.

J Asian Nat Prod Res. 2013;15(4):337-43. doi: 10.1080/10286020.2013.764866. Epub 2013 Feb 19.

PMID:
23421864
2.

Pharmacokinetics and tissue distribution of ginkgolide A, ginkgolide B, and ginkgolide K after intravenous infusion of ginkgo diterpene lactones in a rat model.

Wang S, Ouyang B, Aa J, Geng J, Fei F, Wang P, Wang J, Peng Y, Geng T, Li Y, Huang W, Wang Z, Xiao W, Wang G.

J Pharm Biomed Anal. 2016 Jul 15;126:109-16. doi: 10.1016/j.jpba.2016.04.035. Epub 2016 Apr 25.

PMID:
27182682
3.

[Study on the pharmacokinetics of ginkgolide B for injection in rats].

Zhang XT, Jiao HY, Suo QL.

Zhong Yao Cai. 2012 Mar;35(3):430-3. Chinese.

PMID:
22876684
4.

Pharmacokinetics of the ginkgo B following intravenous administration of ginkgo B emulsion in rats.

Chen WD, Liang Y, Xie L, Lu T, Liu XD, Wang GJ.

Biol Pharm Bull. 2007 Jan;30(1):1-5.

5.

Understanding the regioselective hydrolysis of ginkgolide B under physiological environment based on generation, detection, identification, and semi-quantification of the hydrolyzed products.

Li XJ, Yang K, Du G, Xu L, Lan K.

Anal Bioanal Chem. 2015 Oct;407(26):7945-56. doi: 10.1007/s00216-015-8963-0. Epub 2015 Aug 25.

PMID:
26302962
6.

Effects of food and gender on the pharmacokinetics of ginkgolides A, B, C and bilobalide in rats after oral dosing with ginkgo terpene lactones extract.

Huang P, Zhang L, Chai C, Qian XC, Li W, Li JS, Di LQ, Cai BC.

J Pharm Biomed Anal. 2014 Nov;100:138-144. doi: 10.1016/j.jpba.2014.07.030. Epub 2014 Aug 2.

PMID:
25165009
7.

In vivo biodistribution of ginkgolide B, a constituent of Ginkgo biloba, visualized by MicroPET.

Suehiro M, Simpson NR, Underwood MD, Castrillon J, Nakanishi K, van Heertum R.

Planta Med. 2005 Jul;71(7):622-7.

PMID:
16041647
8.

[Study on pharmacokinetics of ginkgolide B injection in Beagle dogs].

Zhang XT, Jiao HY, Suo QL.

Zhong Yao Cai. 2012 May;35(5):762-5. Chinese.

PMID:
23213741
9.

Urinary and biliary disposition of the lactone and carboxylate forms of 20(S)-camptothecin in rats.

Scott DO, Bindra DS, Sutton SC, Stella VJ.

Drug Metab Dispos. 1994 May-Jun;22(3):438-42.

PMID:
8070321
10.

Pharmacokinetics of lactone, carboxylate and total 9-nitrocamptothecin with different doses and administration routes in rats.

Chen J, Ping Q, Guo J, Chu X, Song M.

Biopharm Drug Dispos. 2006 Mar;27(2):53-9.

PMID:
16299828
11.

Pharmacokinetics of bilobalide, ginkgolide A and B after administration of three different Ginkgo biloba L. preparations in humans.

Woelkart K, Feizlmayr E, Dittrich P, Beubler E, Pinl F, Suter A, Bauer R.

Phytother Res. 2010 Mar;24(3):445-50. doi: 10.1002/ptr.3074.

PMID:
20041430
12.

Pharmacokinetics of Ginkgolide B after Oral Administration of Three Different Ginkgolide B Formulations in Beagle Dogs.

Zhao J, Geng T, Wang Q, Si H, Sun X, Guo Q, Li Y, Huang W, Ding G, Xiao W.

Molecules. 2015 Nov 6;20(11):20031-41. doi: 10.3390/molecules201119678. Erratum in: Molecules. 2016;21(6). pii: E759. doi: 10.3390/molecules21060759.

13.

[In vitro and in vivo stability of 9-nitrocamptothecin lactone form in rats].

Chen J, Ping QN, Guo JX, Liu L, Chu XZ, Song MM.

Yao Xue Xue Bao. 2005 Oct;40(10):888-92. Chinese.

PMID:
16408803
14.

Transport characteristics of ginkgolide B by Caco-2 cells and examination of ginkgolide B oral absorption potential using rat in situ intestinal loop method.

Lv H, Wang G, Wu X, Xie L, Huang C, Li H, Liang Y, Hao H, Sun J.

Int J Pharm. 2008 Mar 3;351(1-2):31-5. Epub 2007 Sep 29.

PMID:
17983711
15.

Plasma pharmacokinetics of lactone and carboxylate forms of 20(S)-camptothecin in anesthetized rats.

Scott DO, Bindra DS, Stella VJ.

Pharm Res. 1993 Oct;10(10):1451-7.

PMID:
8272406
16.

Effect of ginkgolide B on striatal extracellular amino acids in middle cerebral artery occluded rats.

Yang ZZ, Li J, Li SX, Feng W, Wang H.

J Ethnopharmacol. 2011 Jun 14;136(1):117-22. doi: 10.1016/j.jep.2011.04.027. Epub 2011 Apr 16.

PMID:
21527331
17.

Pharmacokinetic studies of ginkgolide K in rat plasma and tissues after intravenous administration using ultra-high performance liquid chromatography-tandem mass spectrometry.

Fan ZY, Liu XG, Guo RZ, Dong X, Gao W, Li P, Yang H.

J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Apr 15;988:1-7. doi: 10.1016/j.jchromb.2015.02.015. Epub 2015 Feb 18.

PMID:
25734938
18.

[Pharmacokinetic properties of Bilobalide and Ginkgolides A and B in healthy subjects after intravenous and oral administration of Ginkgo biloba extract (EGb 761)].

Fourtillan JB, Brisson AM, Girault J, Ingrand I, Decourt JP, Drieu K, Jouenne P, Biber A.

Therapie. 1995 Mar-Apr;50(2):137-44. French.

PMID:
7631288
19.

Synthesis, in silico and in vivo blood brain barrier permeability of ginkgolide B cinnamate.

Lu YM, Pan J, Zhang WN, Hui AL, Guo WQ, Huang L, Zhu QJ, Chen Y.

Fitoterapia. 2015 Oct;106:110-4. doi: 10.1016/j.fitote.2015.08.012. Epub 2015 Aug 29.

PMID:
26327588
20.

Validated LC-MS-MS method for the determination of prodrug of ginkgolide B in rat plasma and brain: application to pharmacokinetic study.

Yuan Y, Pan J, Wu Z, Hui A, Zhou A.

J Chromatogr Sci. 2013 Mar;51(3):266-72. doi: 10.1093/chromsci/bms137. Epub 2012 Aug 29.

PMID:
22933510

Supplemental Content

Support Center